Ideomotor apraxia

Summary

Ideomotor apraxia (MONDO:0006800) is a disease and 3 clinical trials. A subtype of apraxia — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	ideomotor apraxia
Mondo ID	MONDO:0006800
EFO	EFO:1000980
MeSH	D020240
DOID	DOID:4627
SNOMED CT	229706001
UMLS	C0234523
MedGen	115961
MedDRA	10021216
Is cancer (heuristic)	no

Also known as: classic apraxia (finding) [ambiguous] · limb-kinetic apraxia (finding) · transcortical apraxia (finding)

Disease family

This is a subtype of apraxia. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › nervous system disorder › perceptual disorders › apraxia › ideomotor apraxia

Related subtypes (1): gait apraxia

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT00024999	Not specified	COMPLETED	EEG and EMG Analysis of Ideomotor Apraxia
NCT00063115	Not specified	COMPLETED	Using fMRI to Understand the Roles of Brain Areas for Fine Hand Movements
NCT03153371	Not specified	COMPLETED	Early-onset Alzheimer’s Disease Phenotypes: Neuropsychology and Neural Networks